EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns

Marcos M Fonseca iD, Faberson João Mocelin, Marcelo Halfen Grill, Sergio Gianesini iD, Kasuo Miyake, Rodrigo Argenta, Adamastor H Pereira

Phlebology: The Journal of Venous Disease · 2023

DOI: 10.1177/02683555231153533 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phlebology: The Journal of Venous Disease, 2023. Verfasst von Marcos M Fonseca und 6 weiteren Autor:innen. Beteiligte Einrichtung: 28124Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Lasers, Solid-State, Laser Therapy, Telangiectasis, Varicose Veins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryo-Laser & Cryo-Sclerotherapy (CLaCS) is a technique which combines thermal sclerotherapy and injection sclerotherapy. Telangiectasias and small varicosities are targeted by a transdermal laser and right after receive injection sclerotherapy. A cooling device blows −20°C air onto the skin and needle in a pre-, parallel-, and post-fashion.

Objective

Our objective was to establish if there is a difference in result and complications by varying the sclerosing agent but keeping the same ND:Yag long pulse laser parameters in the treatment of small varicosities.

Methods

Fifty five patients were enrolled prospectively and randomized to two groups; in the group 1 dextrose 75% was the sclerosing agent used in combination with the ND:Yag long pulse laser and, in the group 2, the same laser technique was used but the sclerosing agent was polidocanol 0.3% and dextrose 67%.

Results

The results were evaluated 30 days after the treatment by the patients and for blinded evaluators using before and after standardized photos with and without augmented reality. In the patient’s perspective and in the blinded evaluation of the regular photos, no differences between the groups were found. Both groups had low rates of hyperpigmentation and bruising with no statistical difference. Patients treated with polidocanol had less pain after the treatment and a better clearance rate in the photos with augmented reality. No major complications were found.

Conclusion

The treatment of small varicosities with CLaCS using Dextrose 75% or polidocanol 0.3% and Dextrose 67.5% is a safe and effective procedure and both sclerosing agents can be used with similar results. Possibly, in the polidocanol group more nonvisible reticular veins were cleared, but the implication of this find is not clear.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, Solid-StateLaser TherapyTelangiectasisVaricose VeinsHumansSclerosing SolutionsSclerotherapyPolidocanolTreatment OutcomePolyethylene GlycolsGlucose

Stichwörter der Autor:innen

Chronic venous diseaseLeg telangiectasiasclerotherapyvaricose veins

Substanzen

Sclerosing SolutionsPolidocanoldodecylnonaoxyethylene glycol monoetherPolyethylene GlycolsGlucose

Autor:innen und Institutionen

  • 28124Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Clínica Prime Vascular, Porto Alegre, RS, Brazil.
  • 37870Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil.
  • Centro de Estudos Hiroshi Miyake, São Paulo, SP, Brazil.
  • University of Ferrara, Ferrara, ER, Italy.

ORCID-Profile: Marcos M Fonseca, Sergio Gianesini

Zitieren

APA

Fonseca, M. M., Mocelin, F. J., Grill, M. H., Gianesini, S., Miyake, K., Argenta, R., & Pereira, A. H. (2023). Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/02683555231153533

Vancouver

Fonseca MM, Mocelin FJ, Grill MH, Gianesini S, Miyake K, Argenta R, et al. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns. Phlebology: The Journal of Venous Disease. 2023. doi:10.1177/02683555231153533

BibTeX
@article{Fonseca2023,
  author = {Fonseca, Marcos M and Mocelin, Faberson João and Grill, Marcelo Halfen and Gianesini, Sergio and Miyake, Kasuo and Argenta, Rodrigo and Pereira, Adamastor H},
  title = {Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns},
  journal = {Phlebology: The Journal of Venous Disease},
  year = {2023},
  doi = {10.1177/02683555231153533}
}
Kostenlos starten →